Acessibilidade / Reportar erro
This erratum corrects:

Erratum

Sex-differential effects of olanzapine vs. aripiprazole on glucose and lipid metabolism in first-episode schizophrenia

XUE-MEI ZHOU1

http://orcid.org/0000-0002-4774-4432

MAO-RONG HU2

http://orcid.org/0000-0002-8541-2893

MEI-YU GONG1

http://orcid.org/0000-0002-9092-3006

XUE-LIANG ZOU1

http://orcid.org/0000-0003-0688-1550

ZHI-MIN YU1

http://orcid.org/0000-0002-8732-4811

1Jiangxi Mental Health Centre, Nanchang, Jiangxi, China.

2 The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

ZHou XM et al. / Arch Clin Psychiatry. 2019;46(2):33-9

Received: 06/29/2018 – Accepted: 04/02/2019

DOI: 10.1590/0101-60830000000189

On Table 4, where is written:

Table 4. The between-drug and within-drug evolution of the individual metabolic parameter over time in male patients with first-episode schizophrenia assigned to 12 weeks treatment with aripiprazole or olanzapine

NBMI NTG
Baseline, female 0.41 (-0.05–0.88) -0.66 (-1.24–-0.09)
(The 4th weekend - Baseline), female 0.17 (0.01–0.32) 0.70 (0.22–1.18)
(The 8th weekend - Baseline), female 0.26 (0.11–0.42) 0.95 (0.47–1.43)
(The 12th weekend - Baseline), female 0.47 (0.32–0.63) 1.21 (0.73–1.69)
Baseline × (male - female) -0.40 (-1.06–0.26) 0.21 (-0.60–1.03)
The 4th weekend × (male - female) 0.08 (-0.13–0.30) 0 (-0.68–0.68)
The 8th weekend × (male - female) 0.21 (-0.01–-0.42) -0.07 (-0.74–0.61)
The 12th weekend × (male - female) 0.16 (-0.06–-0.38) 0.14 (-0.54–0.82)
  • Data are effect size (95% CI). The measurement units of all laboratory values for the fasting serum levels of lipids and glucose use mmol/L. All indicators are shown by their respective normal score. BMI: body mass index; TG: triglyceride.
  • It should be read:

    Table 4. The between-drug and within-drug evolution of the individual metabolic parameter over time in male patients with first-episode schizophrenia assigned to 12 weeks treatment with aripiprazole or olanzapine

    NBMI NTG
    Baseline, aripiprazole 0.41 (-0.05–0.88) -0.66 (-1.24–-0.09)
    (The 4th weekend - Baseline), aripiprazole 0.17 (0.01–0.32) 0.70 (0.22–1.18)
    (The 8th weekend - Baseline), aripiprazole 0.26 (0.11–0.42) 0.95 (0.47–1.43)
    (The 12th weekend - Baseline), aripiprazole 0.47 (0.32–0.63) 1.21 (0.73–1.69)
    Baseline × (olanzapine - aripiprazole) -0.40 (-1.06–0.26) 0.21 (-0.60–1.03)
    The 4th weekend × (olanzapine - aripiprazole) 0.08 (-0.13–0.30) 0 (-0.68–0.68)
    The 8th weekend × (olanzapine - aripiprazole) 0.21 (-0.01–-0.42) -0.07 (-0.74–0.61)
    The 12th weekend × (olanzapine - aripiprazole) 0.16 (-0.06–-0.38) 0.14 (-0.54–0.82)
  • Data are effect size (95% CI). The measurement units of all laboratory values for the fasting serum levels of lipids and glucose use mmol/L. All indicators are shown by their respective normal score. BMI: body mass index; TG: triglyceride.
  • Address for correspondence: Xue-Mei Zhou. Jiangxi Mental Health Centre. 43 Shangfang Road, Qingshanhu District, 330029, Nanchang, Jiangxi, China. Telephone: 0086-13263912034. E-mail: xlf50@sina.com.cn

    Publication Dates

    • Publication in this collection
      29 July 2019
    • Date of issue
      May-Jun 2019
    Faculdade de Medicina da Universidade de São Paulo Rua Ovídio Pires de Campos, 785 , 05403-010 São Paulo SP Brasil, Tel./Fax: +55 11 2661-8011 - São Paulo - SP - Brazil
    E-mail: archives@usp.br